{"id":"https://openalex.org/W2016325075","doi":"https://doi.org/10.1016/0028-3908(81)90067-8","title":"Multiple opiate receptors: Differential binding of \u03bc, \u03ba and \u03b4 agonists","display_name":"Multiple opiate receptors: Differential binding of \u03bc, \u03ba and \u03b4 agonists","alternate_titles":[],"publication_year":1981,"publication_date":"1981-12-01","ids":{"openalex":"https://openalex.org/W2016325075","doi":"https://doi.org/10.1016/0028-3908(81)90067-8","mag":"2016325075","pmid":"https://pubmed.ncbi.nlm.nih.gov/6275292"},"language":"en","primary_location":{"id":"doi:10.1016/0028-3908(81)90067-8","doi":"https://doi.org/10.1016/0028-3908(81)90067-8","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0028-3908(81)90067-8","pdf_url":null,"source":{"id":"https://openalex.org/S160566677","display_name":"Neuropharmacology","issn_l":"0028-3908","issn":["0028-3908","1873-7064"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-3","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2016325075"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021691550","display_name":"Paul L. Wood","orcid":"https://orcid.org/0000-0002-5853-9936","observed_orcids":["https://orcid.org/0000-0002-5853-9936"]},"institutions":[{"id":"https://openalex.org/I4210095507","display_name":"Merck Canada Inc. (Canada)","ror":"https://ror.org/00rz3ed53","country_code":"CA","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210095507"]}],"countries":["CA"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"P.L. Wood","raw_affiliation_strings":["Department of Pharmacology, Merck Frosst Laboratories, P.O. Box 1005, Pointe Claire-Dorval, Quebec H9R 4P8, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Merck Frosst Laboratories, P.O. Box 1005, Pointe Claire-Dorval, Quebec H9R 4P8, Canada","institution_ids":["https://openalex.org/I4210095507"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031797767","display_name":"Stella E. Charleson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095507","display_name":"Merck Canada Inc. (Canada)","ror":"https://ror.org/00rz3ed53","country_code":"CA","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210095507"]}],"countries":["CA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Stella E. Charleson","raw_affiliation_strings":["Department of Pharmacology, Merck Frosst Laboratories, P.O. Box 1005, Pointe Claire-Dorval, Quebec H9R 4P8, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Merck Frosst Laboratories, P.O. Box 1005, Pointe Claire-Dorval, Quebec H9R 4P8, Canada","institution_ids":["https://openalex.org/I4210095507"]}]},{"author_position":"middle","author":{"id":null,"display_name":"D. Lane","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095507","display_name":"Merck Canada Inc. (Canada)","ror":"https://ror.org/00rz3ed53","country_code":"CA","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210095507"]}],"countries":["CA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"D. Lane","raw_affiliation_strings":["Department of Pharmacology, Merck Frosst Laboratories, P.O. Box 1005, Pointe Claire-Dorval, Quebec H9R 4P8, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Merck Frosst Laboratories, P.O. Box 1005, Pointe Claire-Dorval, Quebec H9R 4P8, Canada","institution_ids":["https://openalex.org/I4210095507"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5014458537","display_name":"Roger L. Hudgin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095507","display_name":"Merck Canada Inc. (Canada)","ror":"https://ror.org/00rz3ed53","country_code":"CA","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210095507"]}],"countries":["CA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"R.L. Hudgin","raw_affiliation_strings":["Department of Pharmacology, Merck Frosst Laboratories, P.O. Box 1005, Pointe Claire-Dorval, Quebec H9R 4P8, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Merck Frosst Laboratories, P.O. Box 1005, Pointe Claire-Dorval, Quebec H9R 4P8, Canada","institution_ids":["https://openalex.org/I4210095507"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5021691550"],"corresponding_institution_ids":["https://openalex.org/I4210095507"],"apc_list":{"value":4300,"currency":"USD","value_usd":4300},"apc_paid":null,"fwci":6.005,"has_fulltext":false,"cited_by_count":205,"citation_normalized_percentile":{"value":0.98010992,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"20","issue":"12","first_page":"1215","last_page":"1220"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10196","display_name":"Pain Mechanisms and Treatments","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13047","display_name":"Pharmacological Receptor Mechanisms and Effects","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/kappa-opioid-receptor","display_name":"kappa opioid receptor","score":0.8740000128746033},{"id":"https://openalex.org/keywords/mu-opioid-receptor","display_name":"mu-opioid receptor","score":0.9850000143051147},{"id":"https://openalex.org/keywords/delta-opioid-receptor","display_name":"delta opioid receptor","score":1.0},{"id":"https://openalex.org/keywords/opioid-receptor-binding","display_name":"opioid receptor binding","score":0.43299999833106995},{"id":"https://openalex.org/keywords/ethylketocyclazocine","display_name":"ethylketocyclazocine","score":0.9010000228881836},{"id":"https://openalex.org/keywords/receptor-agonists","display_name":"receptor agonists","score":0.46299999952316284},{"id":"https://openalex.org/keywords/receptor-antagonists","display_name":"receptor antagonists","score":0.859000027179718},{"id":"https://openalex.org/keywords/pain-relief","display_name":"analgesia","score":0.7329999804496765},{"id":"https://openalex.org/keywords/sigma-opioid-receptor","display_name":"sigma opioid receptor","score":0.7089999914169312},{"id":"https://openalex.org/keywords/receptor-topography","display_name":"receptor topography","score":0.4180000126361847},{"id":"https://openalex.org/keywords/rat-brain","display_name":"rat brain","score":0.7020000219345093}],"concepts":[{"id":"https://openalex.org/C2778140631","wikidata":"https://www.wikidata.org/wiki/Q2026938","display_name":"Opiate","level":3,"score":0.6871941089630127},{"id":"https://openalex.org/C2910977262","wikidata":"https://www.wikidata.org/wiki/Q421797","display_name":"Opiate receptors","level":5,"score":0.6816351413726807},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.6412191987037659},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.6242047548294067},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.609864354133606},{"id":"https://openalex.org/C107824862","wikidata":"https://www.wikidata.org/wiki/Q616005","display_name":"Binding site","level":2,"score":0.5644649863243103},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5464550256729126},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.534832239151001},{"id":"https://openalex.org/C58732023","wikidata":"https://www.wikidata.org/wiki/Q770260","display_name":"Partial agonist","level":4,"score":0.5048797726631165},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.47670668363571167},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.3908681273460388},{"id":"https://openalex.org/C2778750930","wikidata":"https://www.wikidata.org/wiki/Q4540629","display_name":"(+)-Naloxone","level":4,"score":0.3322058916091919},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2976968288421631},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.13290399312973022},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001615","descriptor_name":"beta-Endorphin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004723","descriptor_name":"Endorphins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009294","descriptor_name":"Narcotics","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D009419","descriptor_name":"Nerve Tissue Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011485","descriptor_name":"Protein Binding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011919","descriptor_name":"Rats, Inbred Strains","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011957","descriptor_name":"Receptors, Opioid","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":false},{"descriptor_ui":"D011957","descriptor_name":"Receptors, Opioid","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D017450","descriptor_name":"Receptors, Opioid, mu","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017465","descriptor_name":"Receptors, Opioid, delta","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017473","descriptor_name":"Receptors, Opioid, kappa","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066298","descriptor_name":"In Vitro Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/0028-3908(81)90067-8","doi":"https://doi.org/10.1016/0028-3908(81)90067-8","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0028-3908(81)90067-8","pdf_url":null,"source":{"id":"https://openalex.org/S160566677","display_name":"Neuropharmacology","issn_l":"0028-3908","issn":["0028-3908","1873-7064"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-3","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropharmacology","raw_type":"journal-article"},{"id":"pmid:6275292","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/6275292","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.428600013256073,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":47,"referenced_works":["https://openalex.org/W84535330","https://openalex.org/W1238935559","https://openalex.org/W1775749144","https://openalex.org/W1900414416","https://openalex.org/W1966270902","https://openalex.org/W1974568013","https://openalex.org/W1975652405","https://openalex.org/W1979257935","https://openalex.org/W1995762213","https://openalex.org/W1996906233","https://openalex.org/W1997067332","https://openalex.org/W1997375350","https://openalex.org/W2002307429","https://openalex.org/W2002984493","https://openalex.org/W2003092295","https://openalex.org/W2005530015","https://openalex.org/W2007248430","https://openalex.org/W2008650248","https://openalex.org/W2015538280","https://openalex.org/W2019379768","https://openalex.org/W2022405295","https://openalex.org/W2028116816","https://openalex.org/W2029212708","https://openalex.org/W2044872918","https://openalex.org/W2052900139","https://openalex.org/W2053793579","https://openalex.org/W2054411300","https://openalex.org/W2060518717","https://openalex.org/W2062061004","https://openalex.org/W2075811628","https://openalex.org/W2076701694","https://openalex.org/W2081795763","https://openalex.org/W2087487352","https://openalex.org/W2089359932","https://openalex.org/W2098743730","https://openalex.org/W2131151226","https://openalex.org/W2256287030","https://openalex.org/W2260391429","https://openalex.org/W2299388040","https://openalex.org/W2395996312","https://openalex.org/W2401559053","https://openalex.org/W2410081172","https://openalex.org/W2410492757","https://openalex.org/W2418135300","https://openalex.org/W2466651447","https://openalex.org/W6666189595","https://openalex.org/W6717220218"],"related_works":["https://openalex.org/W2062061004","https://openalex.org/W67342450","https://openalex.org/W1956678414","https://openalex.org/W2032843936","https://openalex.org/W2012435499","https://openalex.org/W1974928956","https://openalex.org/W1974842875","https://openalex.org/W2222628810","https://openalex.org/W2054411300","https://openalex.org/W2032526893"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2016325075","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
